Arch Dermatol
The most recent articles from:
Arch Dermatol
-
Letter Case Reports
Extensive lentigo maligna clearing with topical imiquimod.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
To evaluate the safety and efficacy of botulinum toxin type A (BTX-A) (BOTOX) over 16 months in the treatment of bilateral primary axillary hyperhidrosis. ⋯ Repeated intradermal injections of BTX-A over 16 months for treatment of primary axillary hyperhidrosis is safe and efficacious.